BofA raised the firm’s price target on Agilent to $141 from $138 and keeps a Neutral rating on the shares after the company reported a Q1 core sales decline that was better than expected and EPS 7c ahead of the firm’s and Street’s estimate. While Agilent reported upside in fiscal Q1, FY24 guidance was reiterated as “markets stay rough,” the analyst noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on A: